Cancer in Primary Care Research
15th CAPRI Conference 2024: Equity, policy and transforming care
The 2024 Ca-PRI Cancer in Primary Care Conference is coming to Melbourne, Australia, bringing together leading clinicians and researchers from across the globe. Our 2024 theme is Equity, Policy, and Transforming Care. From prevention to palliative care, we will explore how primary care researchers and health professionals can contribute to improved outcomes in cancer care.
CPD Hours
Education Activity: 9.5
Reviewing Performance: 1
Monitoring Outcomes: 0
Total Hours: 10.5
Delivery mode: Face to face
Frequency: One off
Availability: Open invitation
Target audience
GPs
How to Enrol/More information
PC4 Ca-PRI 2024 Conference (unimelb.edu.au)
PRESIDE Trial Participation
This CPD is part of the PRESIDE Trial. Further information on the trial is available here. As part of this CPD GPs will be able to contribute to research and reflect on their own practice. We will cover consideration of the PGx information when determining the best avenue for treatment of patients’ depressive symptoms (pharmacological or non-pharmacological), as well as follow-up of that patient’s side effects and symptoms. GPs will be provided with a summary of the consultations they have had with the patients enrolled in the trial, in the 6-month follow-up period. This is an opportunity for reflection about the role of PGx testing in their management of depression and their management of mental health generally. Participants can also review the full PGx report and reflect on its potential use in prescribing generally.
RACGP CPD Approved.
CPD Hours
Education Activity: 1
Reviewing Performance: 5
Monitoring Outcomes: 6
Total Hours: 6
Delivery mode: Blended
Availability: By invitation only
Target audience
GPs
How to Enrol/More information
CPD activity only avaliable to GPs participating in the PRESIDE trial. Click here for further information.
PRESIDE GP Qualitative Interviews
Qualitative interviews with education and reflective component for the PRESIDE Trial.
RACGP CPD Approved.
CPD Hours
Education Activity: 0.5
Reviewing Performance: 1.5
Monitoring Outcomes: 0
Total Hours: 2
Delivery mode: Blended
Frequency: Time limited- June 2023 onwards
Availability: By invitation only
Target audience
GPs
How to Enrol/More information
Click here for further information.
IC3 Trial
CPD points are allocated to GP's for participation in the IC3 Trial. This trial will determine if a new cirrhosis detection pathway for liver disease is a feasible and cost effective program, which should be implemented nationally. GP's will take part in an introductory trial information session and will be asked to review patients suitable for the trial. They will be asked to review incidental blood findings and make appropriate referrals to liver specialists during this trial. This trial offers a significant degree of self reflection on current practice of liver health care and all participating GP's will receive and review trial related results at trial end. Participation may affect how they perceive, manage and treat patients in the future, with risk factors for chronic liver disease.
RACGP CPD and ACRRM CPD Approved.